about
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome.CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type IInhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkInhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
P50
description
researcher (ORCID 0000-0001-6693-0989)
@en
wetenschapper
@nl
name
Amaia Vilas-Zornoza
@en
Amaia Vilas-Zornoza
@nl
type
label
Amaia Vilas-Zornoza
@en
Amaia Vilas-Zornoza
@nl
prefLabel
Amaia Vilas-Zornoza
@en
Amaia Vilas-Zornoza
@nl
P31
P496
0000-0001-6693-0989